$3.96
0.04[1.02%]
At close: May 15
$3.96
0[0.00%]
PreMarket: 7:58PM EDT
ProKidney
(NASDAQ:PROK)ProKidney Stock (NASDAQ:PROK), Analyst Ratings, Price Targets, Predictions
ProKidney Corp has a consensus price target of $10.38, established from looking at the 8 latest analyst ratings. The last 3 analyst ratings were released from Morgan Stanley, B of A Securities, and BTIG on March 7, 2024, January 2, 2024, and July 25, 2023. With an average price target of $7 between Morgan Stanley, B of A Securities, and BTIG, there's an implied 76.77% upside for ProKidney Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
B of A Securities
BTIG
Jefferies
Morgan Stanley
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for ProKidney
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/07/2024 | Buy Now | -24.24% | Morgan Stanley | Judah Frommer | → $3 | Assumes | → Equal-Weight | Get Alert |
| 01/02/2024 | Buy Now | -49.49% | B of A Securities | Jason Gerberry | $8 → $2 | Downgrade | Buy → Neutral | Get Alert |
| 07/25/2023 | Buy Now | 304.04% | BTIG | Justin Zelin | → $16 | Initiates | → Buy | Get Alert |
| 12/21/2022 | Buy Now | 278.79% | Jefferies | Kelly Shi | → $15 | Initiates | → Buy | Get Alert |
| 11/10/2022 | Buy Now | 228.28% | Morgan Stanley | Vikram Purohit | → $13 | Initiates | → Equal-Weight | Get Alert |
| 10/18/2022 | Buy Now | 354.55% | UBS | Colin Bristow | → $18 | Initiates | → Buy | Get Alert |
| 10/14/2022 | Buy Now | 304.04% | Citigroup | Yigal Nochomovitz | → $16 | Initiates | → Buy | Get Alert |
| 09/02/2022 | Buy Now | — | Evercore ISI Group | Jonathan Miller | — | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for ProKidney (PROK)?
The latest price target for ProKidney (NASDAQ: PROK) was reported by Morgan Stanley on March 7, 2024. The analyst firm set a price target for $3.00 expecting PROK to fall to within 12 months (a possible -24.24% downside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ProKidney (PROK)?
The latest analyst rating for ProKidney (NASDAQ: PROK) was provided by Morgan Stanley, and ProKidney their equal-weight rating.
When was the last upgrade for ProKidney (PROK)?
There is no last upgrade for ProKidney.
When was the last downgrade for ProKidney (PROK)?
The last downgrade for ProKidney Corp happened on January 2, 2024 when B of A Securities changed their price target from $8 to $2 for ProKidney Corp.
When is the next analyst rating going to be posted or updated for ProKidney (PROK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ProKidney, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ProKidney was filed on March 7, 2024 so you should expect the next rating to be made available sometime around March 7, 2025.
Is the Analyst Rating ProKidney (PROK) correct?
While ratings are subjective and will change, the latest ProKidney (PROK) rating was a with a price target of $0.00 to $3.00. The current price ProKidney (PROK) is trading at is $3.96, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.